Evidence map›Paper›PMID 41039818›Full record

ArticleJournal of extracellular vesicles2025

Heterogeneity of Extracellular Vesicles and Non-Vesicular Nanoparticles in Glioblastoma.

Tuoye Xu, Joao A Paulo, Piyan Zhang, Xinyue Liu, Alya Nguyen, Yuanhua Cheng, Clark Massick, Yanhong Zhang, Dennis K Jeppesen, Qin Zhang and 9 more

Abstract read
In one paragraph

Article in Journal of extracellular vesicles, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Tuoye XuCancer Research Institute, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0002-4057-1241
Joao A PauloDepartment of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA.
Piyan ZhangCancer Research Institute, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Xinyue LiuDepartment of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA.
Alya NguyenDepartment of Chemistry and Bioengineering, University of Washington, Seattle, Washington, USA.
Yuanhua ChengDepartment of Chemistry and Bioengineering, University of Washington, Seattle, Washington, USA.
Clark MassickDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Yanhong ZhangDepartment of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Dennis K JeppesenDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.ORCID https://orcid.org/0000-0002-7480-8083
Qin ZhangDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
James N HigginbothamDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Oleg S TutanovDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Anna M KrichevskyDepartment of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Daniel T ChiuDepartment of Chemistry and Bioengineering, University of Washington, Seattle, Washington, USA.
Steve P GygiDepartment of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA.
Kasey C VickersDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.ORCID https://orcid.org/0000-0001-5643-3102
Jeffrey L FranklinDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Robert J CoffeyDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.ORCID https://orcid.org/0000-0002-2180-3844
Al CharestCancer Research Institute, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.

Funding

Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Non-coding RNA & Bioinformatics CoreP01HL116263 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DAVIES, SEAN STEPHEN · 2014 to 2025
$24.7M
Roles for Supermeres in CRC ProgressionP01CA229123 · NCI · VANDERBILT UNIVERSITY · PI Alissa M Weaver · 2020 to 2026
$12.9M
Integrated approach to study early and late events in colonic neoplasia: mouse to manR35CA197570 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Robert J. Coffey · 2017 to 2026
$9.4M
In Situ Albumin Binding siRNAs for Triple Negative Breast Cancer Tumor Penetration and Molecularly Targeted TherapyR01CA260958 · NCI · VANDERBILT UNIVERSITY · PI COOK, REBECCA SARA, DUVALL, CRAIG LEWIS · 2021 to 2025
$3.0M
Uncovering exRNA and protein determinants of secreted vesicle heterogeneity by flow cytometric purification of vesicle subsets from cells and plasmaUH3CA241685 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI CHAREST, ALAIN, COFFEY, ROBERT J. · 2021 to 2022
$2.1M
Novel functions of plasminogen and its diverse cargo in bloodR01HL173598 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Kasey C Vickers · 2024 to 2026
$1.1M
American Heart Association-American Stroke Association 971070National Institutes of Health grant UG3/UH3 UG3/UH3CA241685(RC,AC)NCI NIH HHS P01 CA229123NCI NIH HHS R01 CA260958NCI NIH HHS R35 CA197570NCI NIH HHS UH3 CA241685NHLBI NIH HHS P01 HL116263NHLBI NIH HHS R01 HL173598NIDDK NIH HHS P30 DK058404
6 · The paper itself

Abstract

It is increasingly clear that intercellular communication is largely mediated by lipid-bilayer, membrane-bound extracellular vesicles (EVs) and amembranous, non-vesicular extracellular particles (NVEPs), including exomeres and the recently identified supermeres. To elucidate the cargo and functional roles of these carriers, we performed a comprehensive analysis of their lipid, protein and RNA content in the context of colorectal cancer and glioblastoma (GBM). Our results demonstrate that EVs exhibit distinct density profiles correlated with specific biomolecular signatures. Moreover, EVs and NVEPs display notable differences in their protein and RNA composition, which confer distinct functional attributes. Supermeres are notably enriched in components involved in extracellular matrix remodeling and possess the ability to cross the blood-brain barrier, a process dependent on their intact structure and RNA content. Once in the central nervous system (CNS), they preferentially engage with microglia and suppress TGFβ1 expression, suggesting a role in modulating microglial immune activity. Furthermore, systemically administered exogenous supermeres selectively accumulate in GBM tumors in vivo. Together, these findings highlight supermeres as a promising vehicle for delivering therapeutics to the CNS and brain tumors.

Indexed as

Brain NeoplasmsExtracellular VesiclesGlioblastomaNanoparticlesAnimalsBlood-Brain BarrierCell CommunicationCell Line, TumorHumansMiceMicrogliaEGFRexomeresextracellular nanoparticlesextracellular vesiclesglioblastomasupermeres

Identifiers

PMID41039818
PMCPMC12491655

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.